|
|
Volumn 65, Issue 1, 2014, Pages 258-259
|
|
No androgen withdrawal syndrome for enzalutamide: A report of disease dynamics in the postchemotherapy setting
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE ACETATE;
BICALUTAMIDE;
CABAZITAXEL;
DOCETAXEL;
ENZALUTAMIDE;
ESTRADIOL;
FINASTERIDE;
HYDROCORTISONE;
HYDROXYFLUTAMIDE;
PROSTATE SPECIFIC ANTIGEN;
ANDROGEN RECEPTOR ANTAGONIST;
PHENYLTHIOHYDANTOIN;
ANDROGEN WITHDRAWAL SYNDROME;
CANCER GROWTH;
CANCER PATIENT;
CANCER RESISTANCE;
CANCER THERAPY;
CASTRATION RESISTANT PROSTATE CANCER;
DRUG MECHANISM;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
MUTATION;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
WITHDRAWAL SYNDROME;
ANALOGS AND DERIVATIVES;
MALE;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SUBSTANCE WITHDRAWAL SYNDROME;
ANDROGEN RECEPTOR ANTAGONISTS;
HUMANS;
MALE;
PHENYLTHIOHYDANTOIN;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SUBSTANCE WITHDRAWAL SYNDROME;
|
|
EID: 84888831566
PISSN: 03022838
EISSN: 18737560
Source Type: Journal
DOI: 10.1016/j.eururo.2013.09.036 Document Type: Letter |
|
Times cited : (18)
|
|
References (6)
|
